Journal of Cystic Fibrosis
Volume 4, Issue 3 , Page 209, September 2005

Measurement of tobramycin and gentamicin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis

Paediatric Respiratory Department, The Royal Brompton Hospital, London, SW36NP, United Kingdom

Microbiology Department, The Royal Brompton Hospital, London, SW3 6NP, United Kingdom

Pharmacy Department, The Royal Brompton Hospital, London, SW3 6NP, United Kingdom

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1569-1993(05)00074-3

doi:10.1016/j.jcf.2005.05.016

Journal of Cystic Fibrosis
Volume 4, Issue 3 , Page 209, September 2005

Article Tools